Clinical Trials for QED Therapeutics

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: QED Therapeutics

Clinical Trials (6)

NCT07169279
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)
PHASE2Not yet recruiting
77 participants
Started: Oct 31, 2025 · Completed: Mar 31, 2032
1 condition1 sponsor13 locations
NCT06873035
An Interventional Study of Infigratinib in Children With Hypochondroplasia
PHASE2/PHASE3Enrolling by invitation
24 participants
Started: May 31, 2025 · Completed: Jan 31, 2027
1 condition1 sponsor22 locations
NCT06410976
Prospective Clinical Assessment Study in Children With Hypochondroplasia
N/ARecruiting
150 participants
Started: Jun 5, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor25 locations
NCT06164951
A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia
PHASE3Active, not recruiting
110 participants
Started: Nov 10, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor28 locations
NCT05145010
Extension Study of Infigratinib in Children With Achondroplasia (ACH)
PHASE2Enrolling by invitation
300 participants
Started: Dec 6, 2021 · Completed: Feb 1, 2032
1 condition1 sponsor29 locations
NCT04035811
Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)
N/AActive, not recruiting
271 participants
Started: Aug 12, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor32 locations